Literature DB >> 10805173

Complexation of iron(III) and iron(II) by citrate. Implications for iron speciation in blood plasma.

L C Königsberger1, E Königsberger, P M May, G T Hefter.   

Abstract

Estimates of the concentrations and identity of the predominant complexes of iron with the low-molecular-mass ligands in vivo are important to improve current understanding of the metabolism of this trace element. These estimates require a knowledge of the stability of the iron-citrate complexes. Previous studies on the equilibrium properties of the Fe(III)-citrate and Fe(II)-citrate are in disagreement. Accordingly, in this work, glass electrode potentiometric titrations have been used to re-determine the formation constants of both the Fe(III)- and Fe(II)-citrate systems at 25 degrees C in 1.00 M (Na)Cl and the reliability of these constants has been evaluated by comparing the measured and predicted redox potentials of the ternary Fe(III)-Fe(II)-citrate system. The formation constants obtained in this way were used in computer simulation models of the low-molecular-mass iron fraction in blood plasma. Redox equilibria of iron are thus included in large models of blood plasma for the first time. The results of these calculations show the predominance of Fe(II)-carbonate complexes and a significant amount of aquated Fe(II) in human blood plasma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10805173     DOI: 10.1016/s0162-0134(99)00222-6

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  13 in total

1.  Mechanistic analysis of iron accumulation by endothelial cells of the BBB.

Authors:  Ryan C McCarthy; Daniel J Kosman
Journal:  Biometals       Date:  2012-03-21       Impact factor: 2.949

2.  Low-molecular-mass iron complexes in blood plasma of iron-deficient pigs do not originate directly from nutrient iron.

Authors:  Nathaniel Dziuba; Joanne Hardy; Paul A Lindahl
Journal:  Metallomics       Date:  2019-10-11       Impact factor: 4.526

3.  Low-molecular-mass iron in healthy blood plasma is not predominately ferric citrate.

Authors:  Nathaniel Dziuba; Joanne Hardy; Paul A Lindahl
Journal:  Metallomics       Date:  2018-06-20       Impact factor: 4.526

Review 4.  Iron transport across the blood-brain barrier: development, neurovascular regulation and cerebral amyloid angiopathy.

Authors:  Ryan C McCarthy; Daniel J Kosman
Journal:  Cell Mol Life Sci       Date:  2014-10-30       Impact factor: 9.261

5.  KCa(H2 O)2 [FeIII (CN)6 ]⋅H2 O Nanoparticles as an Antimicrobial Agent against Staphylococcus aureus.

Authors:  Zhongxia Wang; Bing Yu; Huda Alamri; Sriramakrishna Yarabarla; Min-Ho Kim; Songping D Huang
Journal:  Angew Chem Int Ed Engl       Date:  2018-02-02       Impact factor: 15.336

Review 6.  Beyond iron: non-classical biological functions of bacterial siderophores.

Authors:  Timothy C Johnstone; Elizabeth M Nolan
Journal:  Dalton Trans       Date:  2015-04-14       Impact factor: 4.390

7.  Exploring titanium(IV) chemical proximity to iron(III) to elucidate a function for Ti(IV) in the human body.

Authors:  Manoj Saxena; Sergio A Loza-Rosas; Kavita Gaur; Shweta Sharma; Sofia C Pérez Otero; Arthur D Tinoco
Journal:  Coord Chem Rev       Date:  2018-03-20       Impact factor: 22.315

8.  Nature of non-transferrin-bound iron: studies on iron citrate complexes and thalassemic sera.

Authors:  Robert W Evans; Roozina Rafique; Adel Zarea; Chiara Rapisarda; Richard Cammack; Patricia J Evans; John B Porter; Robert C Hider
Journal:  J Biol Inorg Chem       Date:  2007-09-29       Impact factor: 3.358

9.  Iron metabolism in aerobes: managing ferric iron hydrolysis and ferrous iron autoxidation.

Authors:  Daniel J Kosman
Journal:  Coord Chem Rev       Date:  2013-01-01       Impact factor: 22.315

10.  Iron-binding characterization and polysaccharide production by Klebsiella oxytoca strain isolated from mine acid drainage.

Authors:  F Baldi; D Marchetto; D Battistel; S Daniele; C Faleri; C De Castro; R Lanzetta
Journal:  J Appl Microbiol       Date:  2009-04-10       Impact factor: 3.772

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.